 EXFORGE D
|
Siegfried
|
| valsartán+hidrocloroti.+amlodip. |
Antihipertensivo |
| 160/12.5/10 mg comp.x 28 | $51.705,43 | (21/02/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $25.852,72 |
|
|
|
|
| 160/12.5/5 mg comp.x 28 | $52.202,08 | (21/02/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $26.101,04 |
|
|
|
|
| 160/25/10 mg comp.x 28 | $52.202,08 | (21/02/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $26.101,04 |
|
|
|
|
| 160/25/5 mg comp.x 28 | $52.202,08 | (21/02/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $26.101,04 |
|
|
|
|
| 320/25/10 mg comp.x 28 | $55.206,62 | (21/02/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $27.603,31 |
|
|
|
|
| |
